Twist Bioscience
TWST
84 hedge funds and large institutions have $374M invested in Twist Bioscience in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 12 reducing their positions, and 12 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 12
5.29% more ownership
Funds ownership: 42.85% → 48.14% (+5.3%)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 85 → 84 (-1)
7% less capital invested
Capital invested by funds: $402M → $374M (-$27.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$22.8M |
| 2 |
JP Morgan Chase
New York
|
+$11.6M |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$7.56M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.67M |
| 5 |
Millennium Management
New York
|
+$6.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$14M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.91M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$8.55M |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$3.89M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.36M |
TWST Hedge Fund Activity: Q3 2019 in Review
84 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2019, worth a combined $374M — down 6.8% from $402M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TWST and 11 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 44 added.
The largest buyer was Wells Fargo, adding an estimated $22.8M. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $14M sold.
- 84 institutional investors held Twist Bioscience (TWST) as of Q3 2019, down from 85 in Q2 2019.
- Funds reported $374M of Twist Bioscience stock for Q3 2019, down 6.8% quarter-over-quarter.
- 11 funds opened new Twist Bioscience positions in Q3 2019 and 12 closed out, a net change of -1 holder.
- The largest Twist Bioscience buyer in Q3 2019 was Wells Fargo, an estimated $22.8M added.
- The largest Twist Bioscience seller in Q3 2019 was Schonfeld Strategic Advisors, an estimated $14M sold.
Based on aggregated 13F filings for Q3 2019.